Tirzepatide (Zepbound), a dual GLP-1/GIP agonist, further raised the bar, with mean weight loss exceeding 20% in the SURMOUNT-1 trial
Im thinking of specific patients
Transmission electron microscopy (TEM) (Figure 2) and atomic force microscopy (AFM) assess particle size and morphology (110 nm), while X-ray diffraction (XRD) reveals partial graphitisation with broad peaks near 24 [ 1 ) and G (1,580 cm 1 ) bands, with I_D/I_G ratios which quantify the degree of structural disorder or defects in the carbon lattice [Figure 2) [ FIGURE 2 Overall, the combined influence of nanoscale structure, doping, and surface passivation governs the performance of CQDs
Understanding why sugar cravings persist involves examining how GLP-1 medications affect brain reward pathways, blood sugar regulation, psychological eating patterns, and individual metabolic responses
Epub 2024 Feb 24